Pacific Biosciences of California is a life science technology company that is designing, developing and manufacturing sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Co.'s products address solutions across a set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. Co. has developed HiFi long-read sequencing combined with Single Molecule Real-Time technology, which enables single-molecule, real-time detection of nucleic acid sequences for long-read applications. The PACB stock yearly return is shown above.
The yearly return on the PACB stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PACB annual return calculation with any dividends reinvested as applicable (on ex-dates).
|